164 related articles for article (PubMed ID: 36247012)
1. Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma.
Zhang F; Lin J; Feng D; Liang J; Lu Y; Liu Z; Wang X
Front Cell Dev Biol; 2022; 10():922995. PubMed ID: 36247012
[No Abstract] [Full Text] [Related]
2. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma.
Jiang A; Luo P; Chen M; Fang Y; Liu B; Wu Z; Qu L; Wang A; Wang L; Cai C
Cell Biosci; 2022 Dec; 12(1):209. PubMed ID: 36581992
[TBL] [Abstract][Full Text] [Related]
3. A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
Zhang WT; Gong YM; Zhang CY; Pan JS; Huang T; Li YX
Biomed Res Int; 2022; 2022():9196540. PubMed ID: 36105937
[TBL] [Abstract][Full Text] [Related]
4. Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma.
Zhang F; Lin J; Zhu D; Tang Y; Lu Y; Liu Z; Wang X
Front Oncol; 2022; 12():970208. PubMed ID: 36158645
[TBL] [Abstract][Full Text] [Related]
5. The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma.
Qi X; Wang J; Che X; Li Q; Li X; Wang Q; Wu G
Am J Cancer Res; 2022; 12(8):3947-3966. PubMed ID: 36119838
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance.
Zheng D; Ning J; Xia Y; Ruan Y; Cheng F
Front Oncol; 2022; 12():1008714. PubMed ID: 36387262
[TBL] [Abstract][Full Text] [Related]
7. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma.
Gao Y; Jia Z
Genet Res (Camb); 2022; 2022():6004852. PubMed ID: 36474620
[TBL] [Abstract][Full Text] [Related]
8. A Novel Cuprotosis-Related lncRNA Signature Effectively Predicts Prognosis in Glioma Patients.
Wu S; Ballah AK; Che W; Wang X
J Mol Neurosci; 2023 Mar; 73(2-3):185-204. PubMed ID: 36705778
[TBL] [Abstract][Full Text] [Related]
9. Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma.
Xiao J; Liu Z; Wang J; Zhang S; Zhang Y
Front Oncol; 2022; 12():941211. PubMed ID: 36110946
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.
Yin X; Wang Z; Wang J; Xu Y; Kong W; Zhang J
Oncoimmunology; 2021; 10(1):1933332. PubMed ID: 34262797
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
[TBL] [Abstract][Full Text] [Related]
12. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Li H; Mo Z
Int J Gen Med; 2021; 14():6885-6898. PubMed ID: 34703293
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y
Front Genet; 2022; 13():787884. PubMed ID: 35350243
[No Abstract] [Full Text] [Related]
16. Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma.
Zhu W; Chen Z; Fu M; Li Q; Chen X; Li X; Luo N; Tang W; Yang F; Zhang Y; Zhang Y; Peng X; Hu G
Apoptosis; 2024 Feb; 29(1-2):169-190. PubMed ID: 37713112
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
Xu X; Ding C; Zhong H; Qin W; Shu D; Yu M; Abuduaini N; Zhang S; Yang X; Feng B
Front Immunol; 2023; 14():1165101. PubMed ID: 37006250
[TBL] [Abstract][Full Text] [Related]
18. Machine learning-based characterization of cuprotosis-related biomarkers and immune infiltration in Parkinson's disease.
Zhao S; Zhang L; Ji W; Shi Y; Lai G; Chi H; Huang W; Cheng C
Front Genet; 2022; 13():1010361. PubMed ID: 36338988
[No Abstract] [Full Text] [Related]
19. Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma.
Lv Z; Qi L; Hu X; Mo M; Jiang H; Li Y
Front Oncol; 2021; 11():633950. PubMed ID: 33816274
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic signature predicts overall survival clear cell renal cell carcinoma.
Wang Y; Chen L; Ju L; Qian K; Wang X; Xiao Y; Wang G
Cancer Cell Int; 2020 Nov; 20(1):564. PubMed ID: 33292239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
